This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Learn about the various fees that may come with cash back credit cards. Equip yourself with this knowledge before applying.
22,981 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
Discover what the AENT 2026 earnings transcript reveals about growth, margins, and cash flow. This guide translates t...
Stride stock has fallen significantly over the last year. This article digs into the reasons behind the decline and e...
Small modular reactor stocks trading under $10 can look tempting, but prices don’t always reflect real value. This gu...
BNY Mellon will now support Circle’s USDC on its Digital Asset Custody platform for institutional clients. In a histo...
A routine 2026 cash-out from a CD ladder could lift Medicare premiums in 2028 due to IRMAA lookback rules. Retirees s...
MU surged with the AI boom, then cooled. This guide asks the practical question: should micron technology stock be bo...
Spotting a strong real estate market isn’t guesswork. By watching a few proven metrics that matter: spot—rent growth,...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Delta Air Lines posted a notable weekly gain, with delta stock 9.38% this week, even as retail social chatter turned ...
KBWY remains a high-yield ETF, but payout sustainability is at risk as cannabis REIT tenants face cash-flow headwinds...